Flow chart of study of serology in endemic healthy control individuals (EHC) from baseline serosurvey (year 1) to identification of progressors.

Pie chart and table showing diagnostic methods used in published visceral leishmaniasis clinical studies and the number of patients diagnosed by each method.

Jacob T. Bush (1818121)
Monique Wasunna (157135)
Fabiana Alves (217602)
Jorge Alvar (253327)
Piero L. Olliaro (217564)
Michael Otieno (4413718)
Carol Hopkins Sibley (47580)
Nathalie Strub Wourgaft (3119943)
Philippe J. Guerin (137002)

September 2017

Pie chart and table showing diagnostic methods used in published visceral leishmaniasis clinical ...

Characteristics of the individuals included in the risk factor studies divided by group: Seronegatives, Seroconverters (asymptomatic Leishmania donovani infection) and visceral leishmaniasis (VL) cases.

Albert Picado (194712)
Bart Ostyn (194715)
Shri Prakash Singh (202425)
Surendra Uranw (205473)
Epco Hasker (116130)
Suman Rijal (181185)
Shyam Sundar (58354)
Marleen Boelaert (56961)
François Chappuis (123664)

January 2014

Characteristics of the individuals included in the risk factor studies divided by group: Seronega...

Incidence (cases/10,000/year) of visceral leishmaniasis (VL) in the study area between 2007 and 2015.

Caroline A. Bulstra (6057524)
Epke A. Le Rutte (4955740)
Paritosh Malaviya (228341)
Epco C. Hasker (6057527)
Luc E. Coffeng (278372)
Albert Picado (194712)
Om Prakash Singh (125511)
Marleen C. Boelaert (6057530)
Sake J. de Vlas (69504)
Shyam Sundar (58354)

December 2018

The dashed line represents the WHO 2020 elimination target [10]. Top right panel: distribution of VL...

Population flow chart to allocate the subjects into the three study groups: (1) visceral leishmaniasis (VL) cases, (2) Seroconverters (asymptomatic Leishmania donovani infection) and (3) Seronegatives (DAT negative individuals).

Albert Picado (194712)
Bart Ostyn (194715)
Shri Prakash Singh (202425)
Surendra Uranw (205473)
Epco Hasker (116130)
Suman Rijal (181185)
Shyam Sundar (58354)
Marleen Boelaert (56961)
François Chappuis (123664)

January 2014

Population flow chart to allocate the subjects into the three study groups: (1) visceral leishman...

Bar graph to show Leishmania detected by qPCR in different group of EHC on the basis of their serological status (QP-qPCR positive, QN-qPCR negative, SP-sero positive, SN-sero negative).

Medhavi Sudarshan (205478)
Toolika Singh (673041)
Abhishek Kumar Singh (282106)
Ankita Chourasia (282105)
Bhawana Singh (673042)
Mary E. Wilson (124091)
Jaya Chakravarty (205483)
Shyam Sundar (58354)

December 2014

Bar graph to show Leishmania detected by qPCR in different group of EHC on the basis of their ser...

Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal

Hasker Epco
Malaviya Paritosh
Gidwani Kamlesh
Picado Albert
Ostyn Bart
Kansal Sangeeta
Singh Rudra Pratap
Singh Om Prakash
Chourasia Ankita
Singh Abhishek Kumar
Shankar Ravi
Wilson Mary E.
Khanal Basudha
Rijal Suman
Boelaert Marleen
Sundar Shyam

January 2014

Asymptomatic persons infected with the parasites causing visceral leishmaniasis (VL) usually outnumb...

Graphical presentation of the results comparing each assay by new infection status.

Shih-Wen Lin (106102)
Arpita Ghosh (106103)
Carolina Porras (106105)
Sarah C. Markt (106107)
Ana Cecilia Rodriguez (106109)
Mark Schiffman (106112)
Sholom Wacholder (50226)
Troy J. Kemp (106116)
Ligia A. Pinto (106122)
Paula Gonzalez (106127)
Nicolas Wentzensen (106131)
Mark T. Esser (106136)
Katie Matys (106141)
Ariane Meuree (106144)
Wim Quint (106148)
Leen-Jan van Doorn (106150)
Rolando Herrero (106155)
Allan Hildesheim (106158)
Mahboobeh Safaeian (106160)

January 2013

The results are plotted on the log scale for each assay; the dashed lines represent the standard ...

Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India

Sudarshan Medhavi
Singh Toolika
Singh Abhishek Kumar
Chourasia Ankita
Singh Bhawana
Wilson Mary E.
Chakravarty Jaya
Sundar Shyam

December 2014

infection and as a predictor of progression to symptomatic disease.The study included 1469 healthy ...

Flowchart of the study.

Rebecca M. Koch (4856674)
Matthijs Kox (160002)
Corné van den Kieboom (4856680)
Gerben Ferwerda (60600)
Jelle Gerretsen (636484)
Sandra ten Bruggencate (4856677)
Johannes G. van der Hoeven (160031)
Marien I. de Jonge (527369)
Peter Pickkers (15648)

February 2018

S+ indicates seropositive at baseline; S- indicates seronegative at baseline.</p

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.

Jaya Chakravarty
Epco Hasker
Sangeeta Kansal
Om Prakash Singh
Paritosh Malaviya
Abhishek Kumar Singh
Ankita Chourasia
Toolika Singh
Medhavi Sudarshan
Akhil Pratap Singh
Bhawana Singh
Rudra Pratap Singh
Bart Ostyn
Michaela Fakiola
Albert Picado
Joris Menten
Jenefer M Blackwell
Mary E Wilson
David Sacks
Marleen Boelaert
Shyam Sundar

March 2019

BACKGROUND:Asymptomatic Leishmania donovani infections outnumber clinical presentations, however the...

Antibody and antigen prevalence as indicators of ongoing transmission or elimination of visceral leishmaniasis: a modelling study

Coffeng, Luc E.
Le Rutte, Epke A.
Munoz, Johanna
Adams, Emily
de Vlas, Sake J.

June 2021

Background: Control of visceral leishmaniasis (VL) on the Indian subcontinent has been highly succ...

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study

Jaya Chakravarty (205483)
Epco Hasker (116130)
Sangeeta Kansal (282104)
Om Prakash Singh (125511)
Paritosh Malaviya (228341)
Abhishek Kumar Singh (282106)
Ankita Chourasia (282105)
Toolika Singh (673041)
Medhavi Sudarshan (205478)
Akhil Pratap Singh (4497955)
Bhawana Singh (673042)
Rudra Pratap Singh (228344)
Bart Ostyn (194715)
Michaela Fakiola (73496)
Albert Picado (194712)
Joris Menten (95438)
Jenefer M. Blackwell (125437)
Mary E. Wilson (124091)
David Sacks (192281)
Marleen Boelaert (56961)
Shyam Sundar (58354)

April 2019

BackgroundAsymptomatic Leishmania donovani infections outnumber clinical presentations, however the ...

Flow chart of distribution of subjects enrolled in the study based on presence of serological markers of human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV).

Laura De Marco (310464)
Paola Manzini (136946)
Morena Trevisan (310465)
Anna Gillio-Tos (310467)
Franca Danielle (310469)
Cinzia Balloco (310471)
Alessandra Pizzi (310473)
Eleonora De Filippo (310474)
Sergio D’Antico (310475)
Beatrice Violante (310476)
Adriano Valfrè (310477)
Franco Curti (310478)
Franco Merletti (158831)
Lorenzo Richiardi (158819)

February 2013

Subjects positive for HBsAg and/or HBV-DNA were considered carriers of HBV. Subjects positive for...

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study

Chakravarty, Jaya
Hasker, Epco C.
Kansal, Sangeeta
Singh, Om Prakash
Malaviya, Paritosh
Singh, Abhishek Kumar
Chourasia, Ankita
Singh, Toolika
Sudarshan, Medhavi
Singh, Akhil Pratap
Singh, Bhawana
Singh, Rudra Pratap
Ostyn, Bart
Fakiola, Michaela
Picado, Albert
Menten, Joris
Blackwell, Jenefer M.
Wilson, Mary E.
Sacks, David
Boelaert, Marleen
Sundar, Shyam

Background: Asymptomatic Leishmania donovani infections outnumber clinical presentations, however th...

The flowchart shows that weekly visceral leishmaniasis in human (VLH) infection at every 15 sites (stations).

Anteneh Asmare Godana (6416273)
Samuel Musili Mwalili (6416276)
George Otieno Orwa (6416279)

March 2019

The flowchart shows that weekly visceral leishmaniasis in human (VLH) infection at every 15 sites (s...

Pie chart and table showing diagnostic methods used in published visceral leishmaniasis clinical studies and the number of patients diagnosed by each method.

Jacob T. Bush (1818121)
Monique Wasunna (157135)
Fabiana Alves (217602)
Jorge Alvar (253327)
Piero L. Olliaro (217564)
Michael Otieno (4413718)
Carol Hopkins Sibley (47580)
Nathalie Strub Wourgaft (3119943)
Philippe J. Guerin (137002)

September 2017

Pie chart and table showing diagnostic methods used in published visceral leishmaniasis clinical ...

Characteristics of the individuals included in the risk factor studies divided by group: Seronegatives, Seroconverters (asymptomatic Leishmania donovani infection) and visceral leishmaniasis (VL) cases.

Albert Picado (194712)
Bart Ostyn (194715)
Shri Prakash Singh (202425)
Surendra Uranw (205473)
Epco Hasker (116130)
Suman Rijal (181185)
Shyam Sundar (58354)
Marleen Boelaert (56961)
François Chappuis (123664)

January 2014

Characteristics of the individuals included in the risk factor studies divided by group: Seronega...

Incidence (cases/10,000/year) of visceral leishmaniasis (VL) in the study area between 2007 and 2015.

Caroline A. Bulstra (6057524)
Epke A. Le Rutte (4955740)
Paritosh Malaviya (228341)
Epco C. Hasker (6057527)
Luc E. Coffeng (278372)
Albert Picado (194712)
Om Prakash Singh (125511)
Marleen C. Boelaert (6057530)
Sake J. de Vlas (69504)
Shyam Sundar (58354)

December 2018

The dashed line represents the WHO 2020 elimination target [10]. Top right panel: distribution of VL...

Population flow chart to allocate the subjects into the three study groups: (1) visceral leishmaniasis (VL) cases, (2) Seroconverters (asymptomatic Leishmania donovani infection) and (3) Seronegatives (DAT negative individuals).

Albert Picado (194712)
Bart Ostyn (194715)
Shri Prakash Singh (202425)
Surendra Uranw (205473)
Epco Hasker (116130)
Suman Rijal (181185)
Shyam Sundar (58354)
Marleen Boelaert (56961)
François Chappuis (123664)

January 2014

Population flow chart to allocate the subjects into the three study groups: (1) visceral leishman...

Bar graph to show Leishmania detected by qPCR in different group of EHC on the basis of their serological status (QP-qPCR positive, QN-qPCR negative, SP-sero positive, SN-sero negative).

Medhavi Sudarshan (205478)
Toolika Singh (673041)
Abhishek Kumar Singh (282106)
Ankita Chourasia (282105)
Bhawana Singh (673042)
Mary E. Wilson (124091)
Jaya Chakravarty (205483)
Shyam Sundar (58354)

December 2014

Bar graph to show Leishmania detected by qPCR in different group of EHC on the basis of their ser...

Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal

Hasker Epco
Malaviya Paritosh
Gidwani Kamlesh
Picado Albert
Ostyn Bart
Kansal Sangeeta
Singh Rudra Pratap
Singh Om Prakash
Chourasia Ankita
Singh Abhishek Kumar
Shankar Ravi
Wilson Mary E.
Khanal Basudha
Rijal Suman
Boelaert Marleen
Sundar Shyam

January 2014

Asymptomatic persons infected with the parasites causing visceral leishmaniasis (VL) usually outnumb...

Graphical presentation of the results comparing each assay by new infection status.

Shih-Wen Lin (106102)
Arpita Ghosh (106103)
Carolina Porras (106105)
Sarah C. Markt (106107)
Ana Cecilia Rodriguez (106109)
Mark Schiffman (106112)
Sholom Wacholder (50226)
Troy J. Kemp (106116)
Ligia A. Pinto (106122)
Paula Gonzalez (106127)
Nicolas Wentzensen (106131)
Mark T. Esser (106136)
Katie Matys (106141)
Ariane Meuree (106144)
Wim Quint (106148)
Leen-Jan van Doorn (106150)
Rolando Herrero (106155)
Allan Hildesheim (106158)
Mahboobeh Safaeian (106160)

January 2013

The results are plotted on the log scale for each assay; the dashed lines represent the standard ...

Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India

Sudarshan Medhavi
Singh Toolika
Singh Abhishek Kumar
Chourasia Ankita
Singh Bhawana
Wilson Mary E.
Chakravarty Jaya
Sundar Shyam

December 2014

infection and as a predictor of progression to symptomatic disease.The study included 1469 healthy ...

Flowchart of the study.

Rebecca M. Koch (4856674)
Matthijs Kox (160002)
Corné van den Kieboom (4856680)
Gerben Ferwerda (60600)
Jelle Gerretsen (636484)
Sandra ten Bruggencate (4856677)
Johannes G. van der Hoeven (160031)
Marien I. de Jonge (527369)
Peter Pickkers (15648)

February 2018

S+ indicates seropositive at baseline; S- indicates seronegative at baseline.</p

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.

Jaya Chakravarty
Epco Hasker
Sangeeta Kansal
Om Prakash Singh
Paritosh Malaviya
Abhishek Kumar Singh
Ankita Chourasia
Toolika Singh
Medhavi Sudarshan
Akhil Pratap Singh
Bhawana Singh
Rudra Pratap Singh
Bart Ostyn
Michaela Fakiola
Albert Picado
Joris Menten
Jenefer M Blackwell
Mary E Wilson
David Sacks
Marleen Boelaert
Shyam Sundar

March 2019

BACKGROUND:Asymptomatic Leishmania donovani infections outnumber clinical presentations, however the...

Antibody and antigen prevalence as indicators of ongoing transmission or elimination of visceral leishmaniasis: a modelling study

Coffeng, Luc E.
Le Rutte, Epke A.
Munoz, Johanna
Adams, Emily
de Vlas, Sake J.

June 2021

Background: Control of visceral leishmaniasis (VL) on the Indian subcontinent has been highly succ...

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study

Jaya Chakravarty (205483)
Epco Hasker (116130)
Sangeeta Kansal (282104)
Om Prakash Singh (125511)
Paritosh Malaviya (228341)
Abhishek Kumar Singh (282106)
Ankita Chourasia (282105)
Toolika Singh (673041)
Medhavi Sudarshan (205478)
Akhil Pratap Singh (4497955)
Bhawana Singh (673042)
Rudra Pratap Singh (228344)
Bart Ostyn (194715)
Michaela Fakiola (73496)
Albert Picado (194712)
Joris Menten (95438)
Jenefer M. Blackwell (125437)
Mary E. Wilson (124091)
David Sacks (192281)
Marleen Boelaert (56961)
Shyam Sundar (58354)

April 2019

BackgroundAsymptomatic Leishmania donovani infections outnumber clinical presentations, however the ...

Flow chart of distribution of subjects enrolled in the study based on presence of serological markers of human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV).

Laura De Marco (310464)
Paola Manzini (136946)
Morena Trevisan (310465)
Anna Gillio-Tos (310467)
Franca Danielle (310469)
Cinzia Balloco (310471)
Alessandra Pizzi (310473)
Eleonora De Filippo (310474)
Sergio D’Antico (310475)
Beatrice Violante (310476)
Adriano Valfrè (310477)
Franco Curti (310478)
Franco Merletti (158831)
Lorenzo Richiardi (158819)

February 2013

Subjects positive for HBsAg and/or HBV-DNA were considered carriers of HBV. Subjects positive for...

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study

Chakravarty, Jaya
Hasker, Epco C.
Kansal, Sangeeta
Singh, Om Prakash
Malaviya, Paritosh
Singh, Abhishek Kumar
Chourasia, Ankita
Singh, Toolika
Sudarshan, Medhavi
Singh, Akhil Pratap
Singh, Bhawana
Singh, Rudra Pratap
Ostyn, Bart
Fakiola, Michaela
Picado, Albert
Menten, Joris
Blackwell, Jenefer M.
Wilson, Mary E.
Sacks, David
Boelaert, Marleen
Sundar, Shyam

Background: Asymptomatic Leishmania donovani infections outnumber clinical presentations, however th...

The flowchart shows that weekly visceral leishmaniasis in human (VLH) infection at every 15 sites (stations).

Anteneh Asmare Godana (6416273)
Samuel Musili Mwalili (6416276)
George Otieno Orwa (6416279)

March 2019

The flowchart shows that weekly visceral leishmaniasis in human (VLH) infection at every 15 sites (s...

Pie chart and table showing diagnostic methods used in published visceral leishmaniasis clinical studies and the number of patients diagnosed by each method.

Jacob T. Bush (1818121)
Monique Wasunna (157135)
Fabiana Alves (217602)
Jorge Alvar (253327)
Piero L. Olliaro (217564)
Michael Otieno (4413718)
Carol Hopkins Sibley (47580)
Nathalie Strub Wourgaft (3119943)
Philippe J. Guerin (137002)

September 2017

Pie chart and table showing diagnostic methods used in published visceral leishmaniasis clinical ...

Characteristics of the individuals included in the risk factor studies divided by group: Seronegatives, Seroconverters (asymptomatic Leishmania donovani infection) and visceral leishmaniasis (VL) cases.

Albert Picado (194712)
Bart Ostyn (194715)
Shri Prakash Singh (202425)
Surendra Uranw (205473)
Epco Hasker (116130)
Suman Rijal (181185)
Shyam Sundar (58354)
Marleen Boelaert (56961)
François Chappuis (123664)

January 2014

Characteristics of the individuals included in the risk factor studies divided by group: Seronega...

Incidence (cases/10,000/year) of visceral leishmaniasis (VL) in the study area between 2007 and 2015.

Caroline A. Bulstra (6057524)
Epke A. Le Rutte (4955740)
Paritosh Malaviya (228341)
Epco C. Hasker (6057527)
Luc E. Coffeng (278372)
Albert Picado (194712)
Om Prakash Singh (125511)
Marleen C. Boelaert (6057530)
Sake J. de Vlas (69504)
Shyam Sundar (58354)

December 2018

The dashed line represents the WHO 2020 elimination target [10]. Top right panel: distribution of VL...

Flow chart of study of serology in endemic healthy control individuals (EHC) from baseline serosurvey (year 1) to identification of progressors.

Abstract

Extracted data

Flow chart of study of serology in endemic healthy control individuals (EHC) from baseline serosurvey (year 1) to identification of progressors.

Abstract

Extracted data

Related items

Related items